In a regulatory filing, Cardiff Oncology disclosed that its director Gary Pace bought 30K shares of common stock on December 19th in a total transaction size of $41.1K. Share of Cardiff Oncology are up 3% afterhours.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRDF:
